DEF 14A: Maquia Capital Acquisition Corporation Seeks Extension to Complete Business Combination

Sentiment:

Proxy Statement


Maquia Capital Acquisition Corporation is seeking stockholder approval to extend the deadline for completing a business combination from February 7, 2025, to February 7, 2026.

Delay expectedThe company is seeking an extension to complete its business combination, indicating a delay in finalizing a deal within the original timeframe.
Worse than expectedThe company is seeking an extension to complete its business combination, indicating that it has not been able to finalize a deal within the original timeframe.The company inadvertently extended the date by which the business combination was to be completed to January 7th, 2025 due to scriveners error, instead of the intended date of February 7th 2025.

Summary

  • Maquia Capital Acquisition Corporation is seeking stockholder approval to amend its charter to extend the date by which it must complete a business combination from February 7, 2025, to February 7, 2026.
  • The company has scheduled a special meeting of stockholders for January 31, 2025, to vote on the extension amendment proposal and a proposal to adjourn the meeting if necessary.
  • Public stockholders have the option to redeem their shares for approximately $12.01 per share from the trust account, regardless of how they vote on the extension amendment proposal.
  • If the extension amendment proposal is not approved, the company will liquidate and distribute the funds in the trust account to public stockholders.
  • The Sponsor and the Representative will not receive any monies held in the Trust Account as a result of their ownership of the Founder Shares or the Private Placement Units, as applicable.
  • The company has entered into a Business Combination Agreement with Velocium, Inc. on July 15, 2024.
  • The Sponsor and insiders, owning approximately 92.74% of the outstanding shares, are expected to vote in favor of the extension.
  • Approval of the Extension Amendment Proposal requires the affirmative vote of at least 65% of the company's outstanding shares of common stock.
  • The company has engaged Advantage Proxy to assist in the solicitation of proxies for the Meeting for a fee of $7,500.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative. While the extension provides more time to complete a deal, it also indicates that the company has not been able to find a suitable target within the original timeframe. The high insider ownership and potential for redemptions add uncertainty.

Positives

  • The extension provides additional time to complete the proposed business combination with Velocium, Inc.
  • Stockholders retain the right to redeem their shares if they disapprove of the business combination, even if the extension is approved.
  • The Sponsor is incentivized to complete a business combination as their shares and private placement units would expire worthless upon liquidation.
  • The company has secured a business combination agreement with Velocium, Inc. on July 15, 2024.

Negatives

  • If the extension is approved, the amount remaining in the trust account will be reduced due to redemptions.
  • There is no guarantee that a business combination will be completed even if the extension is approved.
  • The Sponsor's and insiders' interests may not align with those of public stockholders.
  • The company inadvertently extended the date by which the business combination was to be completed to January 7th, 2025 due to scriveners error, instead of the intended date of February 7th 2025.

Risks

  • There are no assurances that the Extension will enable the company to complete a Business Combination.
  • Redemptions may leave the company with insufficient cash to consummate a Business Combination on commercially acceptable terms, or at all.
  • A 1% U.S. federal excise tax may be imposed on the company in connection with redemptions of shares.
  • Changes to laws or regulations may adversely affect the company's business, including its ability to negotiate and complete its initial Business Combination.
  • The company may be deemed an investment company for purposes of the Investment Company Act, which would require burdensome compliance requirements and severely restrict its activities.
  • The company may not be able to complete a Business Combination with certain potential target companies if a proposed transaction with the target company may be subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations.
  • The company may be deemed a foreign person under the regulations relating to CFIUS and its failure to obtain any required approvals within the requisite time period may require it to liquidate.

Future Outlook

The company intends to continue working to consummate the Business Combination by the Extended Date. The company will remain a reporting company under the Exchange Act and its units, Class A common stock and public warrants will remain publicly traded.

Management Comments

  • The Board believes that it is in the best interests of the stockholders to continue our existence until the Extended Date in order to allow us more time to complete the Business Combination.
  • Our Board believes stockholders should have an opportunity to evaluate the Business Combination.

Industry Context

This announcement is typical for SPACs approaching their deadline for completing a business combination. Many SPACs seek extensions to provide more time to find and complete a suitable merger target.

Comparison to Industry Standards

  • The redemption price of approximately $12.01 per share is above the typical $10.00 NAV (net asset value) per share for SPACs, indicating potential interest income earned in the trust account.
  • The percentage of shares owned by the sponsor and insiders (92.74%) is relatively high, which could influence the outcome of the vote on the extension amendment proposal.
  • The engagement of a proxy solicitor for $7,500 is a standard practice for SPACs seeking extensions or merger approvals.

Stakeholder Impact

  • Stockholders have the option to redeem their shares, potentially reducing the funds available for the business combination.
  • If the extension is not approved, stockholders will receive a pro rata share of the trust account upon liquidation.
  • The Sponsor and insiders face the risk of their shares and private placement units expiring worthless upon liquidation.

Next Steps

  • Stockholders will vote on the extension amendment proposal at the special meeting on January 31, 2025.
  • If the extension is approved, the company will continue to work towards completing the business combination with Velocium, Inc.
  • The company will hold another stockholder meeting prior to the Extended Date in order to seek stockholder approval of the Business Combination.

Key Dates

DateDescription
December 10, 2020Date of filing of the Corporation's Certificate of Incorporation.
May 4, 2021Date of filing of the Amended and Restated Certificate of Incorporation.
May 7, 2021Date of consummation of the IPO.
November 4, 2022Date of filing of the First Amendment to the Amended and Restated Certificate of Incorporation.
April 7, 2023Date of filing of the Second Amendment to the Amended and Restated Certificate of Incorporation.
January 24, 2024SEC adopted the previously proposed rules (the SPAC Rules).
January 29, 2024Date of filing of the Third Amendment to the Amended and Restated Certificate of Incorporation.
April 16, 2024Date of filing of the Annual Report on Form 10-K with the SEC.
June 28, 2024The total amount deposited by the Sponsor since the IPO is $11,963,543.
July 15, 2024Date of entering into a Business Combination Agreement with Velocium, Inc.
July 31, 2024Date of filing of the Fourth Amendment to the Amended and Restated Certificate of Incorporation.
January 3, 2025Record date for determining stockholders entitled to receive notice of and vote at the Meeting.
January 6, 2025The closing price of the Company's Class A common stock was $11.29.
January 7, 2025The closing price of the Company's Class A common stock was $11.29.
January 13, 2025Date of the Proxy Statement.
January 15, 2025Date the Proxy Statement is first being mailed to stockholders.
January 28, 2025Date of the Board of Directors order.
January 29, 2025Deadline for stockholders to tender their shares for redemption (5:00 p.m. Eastern Time).
January 31, 2025Date of the Special Meeting of Stockholders (10:00 a.m. Eastern Time).
February 7, 2025Original deadline for completing a business combination.
February 7, 2026Proposed extended deadline for completing a business combination.

Keywords

business combination, extension amendment, redemption rights, special meeting, trust account, liquidation, SPAC, proxy, shares, stockholders

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.